firstly - I am very interested in the NW USA manufacturing plant - if anyone can elaborate on that.. would be much appreciated!!
OK - I had to do it.. was going to leave it and go to bed.. but I just had to!
I said I'd re-do my calcs after the meeting anyway.. I will use 'real/conservative' figures in this calc.
And 65% gross margin =) gotta be happy with that! We were assuming 35% gross margin before !
OK here she comes:
40,000 courses sold by FY09 US$650 per course 250m shares PE of 20
40,000 x 650 = $26m net profit before tax 26m / 250m shares = 10.4c x 15 = $2.08 per share from Ropren sales ALONE.
BIO A sales to have a substantial impact on the bottom line also.
PE of 20? I would dare say by this time next year we'll have a higher PE.. but we'll stick to this for conservatism sake.
Gosh. Please dont say I'm a ramper. These sales are GOING TO HAPPEN !! Scutinise as much as you like =) While BioA sales are happening in the background =) =) alright time to hit the sack!
SLA Price at posting:
67.3¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)